Cryo-Cell Research and Development Expenses 2010-2024 | CCEL

Cryo-Cell research and development expenses from 2010 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.

Cryo-Cell Research and Development Expenses 2010-2024 | CCEL

Cryo-Cell research and development expenses from 2010 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
Related Stocks
Company NameMarket
Cap
Elevance Health (ELV)$95.8B
Cencora (COR)$49B
DiDi Global (DIDIY)$23.3B
ICON (ICLR)$17.5B
Natera (NTRA)$16.7B
Viatris (VTRS)$15.4B
Avantor (AVTR)$14.8B
Revvity (RVTY)$14.6B
BioMerieux (BMXMF)$12.9B
CochLear (CHEOY)$12.7B
Solventum (SOLV)$12.2B
Medpace Holdings (MEDP)$11.2B
Charles River Laboratories (CRL)$11B
Doximity (DOCS)$10.8B
HealthEquity (HQY)$8.7B
Sonic Healthcare (SKHHY)$8.5B
Bausch + Lomb (BLCO)$6.9B
Life Times (LTH)$5B
Sotera Health (SHC)$4.4B
Organon (OGN)$4B
Surgery Partners (SGRY)$3.8B
BrightSpring Health Services (BTSG)$3.4B
PACS (PACS)$3.1B
Concentras Parent (CON)$2.6B
Alignment Healthcare (ALHC)$2.5B
Ardent Health Partners (ARDT)$2.4B
Premier (PINC)$2.3B
GeneDx Holdings (WGS)$2.1B
Ryman Healthcare (RYHTY)$2B
GoodRx Holdings (GDRX)$1.8B